Drugmaker Plans $125 Million Note Offering

Nabi Biopharmaceuticals said it intends to offer $125 million in notes to raise money for, among other things, clinical trials. The dollar amount is for the total principal amount of senior convertible notes due 2025. The offering would be to qualified institutional buyers.

The South Florida Business Journal (http://www.bizjournals.com/southflorida/stories/2005/04/11/daily14.html)